Notably, the proportion of immunosuppressive Tregs (CD4+Foxp3+), on the other hand, decreased significantly (Fig. 7U and V), which is beneficial for enhancing overall anti-tumor immunity. This evidence concerns the gene FOXP3 and neoplasm.